Plus   Neg

EnteroMedics Inc. (ETRM) Broke Out To A 10-Month High On Study Results

EnteroMedics Inc. (ETRM) announced results from its 5 year ReCharge Pivotal Trial of VBLOC vagal blocking therapy for the treatment of obesity Tuesday morning. Patients in the VBLOC group achieved excess weight loss of 25%, or 10% total body weight loss, compared to 12% excess weight loss, or 4% total body weight loss for control group patients.

EnteroMedics rose sharply in early trade Tuesday and advanced further going into the close. The stock finished up by 0.87 at $2.24 on the highest volume of the year. EnteroMedics surged to nearly a 10-month high.

For comments and feedback contact: editorial@rttnews.com

Business News

Follow RTT